Clinical Trial Update: Effects of Cyclosporine A on Pancreatic Insulin Secretion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of cyclosporine A on pancreatic insulin secretion in patients with chronic kidney disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Chronic Renal Failure | Phase 4 | Status: COMPLETED